Development to significantly expand Else’s product offering depth and reach to a global audience
VANCOUVER, BC , October 28, 2021 – ELSE NUTRITION HOLDINGS INC. (BABY.V) (BABYF) (0YL.F) (“Else” or the “Company”) the Plant-Based baby, toddler and children nutrition company, today announced that it will be expanding its current line of Plant-Based Nutrition products with U.S.-based, international online retailer iHerb inc. Planed for November 2021, Else’s Plant-Powered Complete Nutrition Shakes for Kids will be available on iHerb.com, in both chocolate and vanilla flavors.
“Our distribution partnership with iHerb Inc. continues to grow with great progress,” said Hamutal Yitzhak, CEO, and Co-Founder of Else Nutrition. “Our relationship with iHerb continues with great momentum through iHerb’s online sales platform and ensures Else products are accessible to Plant-Based wanting consumers worldwide, she added.”
The agreement expands Else Nutrition’s offering on iHerb, and its gateway to global online consumers.
About iHerb, Inc.
iHerb Inc. retails nutritional and healthcare products across the United States and globally. The Company provides supplements, herbs, bathing and beauty products, grocery, kids accessories, and sports goods. Since 1996, the foundation and mission of iHerb has been built on providing a wide selection of health and wellness products to individuals around the globe at a reasonable cost. With a headquarters in Morena Valley, California and various warehouses in the United States, iHerb’s team of 1,600 dedicated professionals is deeply committed to the environment, and through several different eco-friendly initiatives, promotes recycling and the limit of waste throughout the company.
About Else Nutrition Holdings Inc.
Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan. Else Plant-Based Complete Nutrition for Toddlers was recently ranked as the #1 Top seller in the baby and toddler formula category on Amazon. The holding company, Else Nutrition Holdings Inc., is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executives include leaders hailing from leading infant nutrition companies. Many of Else advisory board members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children’s Medical Center of Israel, Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium.
For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.
For more information, contact:
Mrs. Hamutal Yitzhak, CEO, Co-Founder & Director
ELSE Nutrition Holdings Inc.
Mr. Sokhie Puar, Lead Director of Else Nutrition
US Investor Relations Contact
Lytham Partners, LLC
Mr. Ben Shamsian
New York | Phoenix
TSX Venture Exchange
Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Caution Regarding Forward-Looking Statements
This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will” or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company’s financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that there will be no interruptions or supply chain failures as a result of COVID 19 and that the manufacturing, broker and supply logistic agreement with the Company do not terminate. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.